{"id":"https://openalex.org/W4283697159","doi":"https://doi.org/10.1186/s12943-022-01601-0","title":"Ceritinib is a novel triple negative breast cancer therapeutic agent","display_name":"Ceritinib is a novel triple negative breast cancer therapeutic agent","publication_year":2022,"publication_date":"2022-06-29","ids":{"openalex":"https://openalex.org/W4283697159","doi":"https://doi.org/10.1186/s12943-022-01601-0","pmid":"https://pubmed.ncbi.nlm.nih.gov/35768871","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9241294"},"language":"en","primary_location":{"id":"doi:10.1186/s12943-022-01601-0","doi":"https://doi.org/10.1186/s12943-022-01601-0","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12943-022-01601-0","pdf_url":null,"source":{"id":"https://openalex.org/S132829192","display_name":"Molecular Cancer","issn_l":"1476-4598","issn":["1476-4598"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1186/s12943-022-01601-0","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100939059","display_name":"Shengli Dong","orcid":"https://orcid.org/0009-0005-5798-6477","observed_orcids":["https://orcid.org/0009-0005-5798-6477"]},"institutions":[{"id":"https://openalex.org/I4405283994","display_name":"TYK Medicines, Inc.","ror":"https://ror.org/02pz3ch87","country_code":"CN","type":"company","lineage":["https://openalex.org/I4405283994"]},{"id":"https://openalex.org/I75420490","display_name":"Louisiana State University Health Sciences Center New Orleans","ror":"https://ror.org/01qv8fp92","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121820613","https://openalex.org/I75420490"]}],"countries":["CN","US"],"is_corresponding":false,"raw_author_name":"Shengli Dong","raw_affiliation_strings":["Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, LA, 70112, USA","TYK Medicines, Inc, Zhejiang, People's Republic of China, 313100"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, LA, 70112, USA","institution_ids":["https://openalex.org/I75420490"]},{"raw_affiliation_string":"TYK Medicines, Inc, Zhejiang, People's Republic of China, 313100","institution_ids":["https://openalex.org/I4405283994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107169509","display_name":"Hassan Yousefi","orcid":"https://orcid.org/0000-0002-5867-1531","observed_orcids":["https://orcid.org/0000-0002-5867-1531"]},"institutions":[{"id":"https://openalex.org/I75420490","display_name":"Louisiana State University Health Sciences Center New Orleans","ror":"https://ror.org/01qv8fp92","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121820613","https://openalex.org/I75420490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hassan Yousefi","raw_affiliation_strings":["Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, LA, 70112, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, LA, 70112, USA","institution_ids":["https://openalex.org/I75420490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082611102","display_name":"Isabella Van Savage","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114832834","display_name":"Tulane University","ror":"https://ror.org/04vmvtb21","country_code":"US","type":"education","lineage":["https://openalex.org/I114832834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Isabella Van Savage","raw_affiliation_strings":["Tulane University School of Medicine, New Orleans, Louisiana, 70118, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tulane University School of Medicine, New Orleans, Louisiana, 70118, USA","institution_ids":["https://openalex.org/I114832834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037496944","display_name":"Samuel C. Okpechi","orcid":"https://orcid.org/0009-0008-3679-2915","observed_orcids":["https://orcid.org/0009-0008-3679-2915"]},"institutions":[{"id":"https://openalex.org/I75420490","display_name":"Louisiana State University Health Sciences Center New Orleans","ror":"https://ror.org/01qv8fp92","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121820613","https://openalex.org/I75420490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samuel C. Okpechi","raw_affiliation_strings":["Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, LA, 70112, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, LA, 70112, USA","institution_ids":["https://openalex.org/I75420490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004862228","display_name":"Maryl K. Wright","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114832834","display_name":"Tulane University","ror":"https://ror.org/04vmvtb21","country_code":"US","type":"education","lineage":["https://openalex.org/I114832834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maryl K. Wright","raw_affiliation_strings":["Tulane University School of Medicine, New Orleans, Louisiana, 70118, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tulane University School of Medicine, New Orleans, Louisiana, 70118, USA","institution_ids":["https://openalex.org/I114832834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041222618","display_name":"Margarite D. Matossian","orcid":"https://orcid.org/0000-0002-9527-1043","observed_orcids":["https://orcid.org/0000-0002-9527-1043"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margarite D. Matossian","raw_affiliation_strings":["Department of Medicine, The University of Chicago, Chicago, IL, 60637, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, The University of Chicago, Chicago, IL, 60637, USA","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063837076","display_name":"Bridgette M. Collins\u2010Burow","orcid":"https://orcid.org/0000-0003-0039-6415","observed_orcids":["https://orcid.org/0000-0003-0039-6415"]},"institutions":[{"id":"https://openalex.org/I114832834","display_name":"Tulane University","ror":"https://ror.org/04vmvtb21","country_code":"US","type":"education","lineage":["https://openalex.org/I114832834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bridgette M. Collins-Burow","raw_affiliation_strings":["Tulane University School of Medicine, New Orleans, Louisiana, 70118, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tulane University School of Medicine, New Orleans, Louisiana, 70118, USA","institution_ids":["https://openalex.org/I114832834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048983251","display_name":"Matthew E. Burow","orcid":"https://orcid.org/0000-0002-0642-6630","observed_orcids":["https://orcid.org/0000-0002-0642-6630"]},"institutions":[{"id":"https://openalex.org/I114832834","display_name":"Tulane University","ror":"https://ror.org/04vmvtb21","country_code":"US","type":"education","lineage":["https://openalex.org/I114832834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew E. Burow","raw_affiliation_strings":["Tulane University School of Medicine, New Orleans, Louisiana, 70118, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tulane University School of Medicine, New Orleans, Louisiana, 70118, USA","institution_ids":["https://openalex.org/I114832834"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049332865","display_name":"Suresh K. Alahari","orcid":"https://orcid.org/0000-0002-9651-6727","observed_orcids":["https://orcid.org/0000-0002-9651-6727"]},"institutions":[{"id":"https://openalex.org/I75420490","display_name":"Louisiana State University Health Sciences Center New Orleans","ror":"https://ror.org/01qv8fp92","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121820613","https://openalex.org/I75420490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Suresh K. Alahari","raw_affiliation_strings":["Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, LA, 70112, USA. salaha@lsuhsc.edu","Stanley S. Scott Cancer Center, LSUHSC School of Medicine, New Orleans, LA, 70112, USA. salaha@lsuhsc.edu","Stanley S. Scott Cancer Center, LSUHSC School of Medicine, New Orleans, LA, 70112, USA"],"raw_orcid":"https://orcid.org/0000-0002-9651-6727","affiliations":[{"raw_affiliation_string":"Department of Biochemistry and Molecular Biology, LSUHSC School of Medicine, New Orleans, LA, 70112, USA. salaha@lsuhsc.edu","institution_ids":["https://openalex.org/I75420490"]},{"raw_affiliation_string":"Stanley S. Scott Cancer Center, LSUHSC School of Medicine, New Orleans, LA, 70112, USA. salaha@lsuhsc.edu","institution_ids":["https://openalex.org/I75420490"]},{"raw_affiliation_string":"Stanley S. Scott Cancer Center, LSUHSC School of Medicine, New Orleans, LA, 70112, USA","institution_ids":["https://openalex.org/I75420490"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5049332865"],"corresponding_institution_ids":["https://openalex.org/I75420490"],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":{"value":4690,"currency":"USD","value_usd":4690},"fwci":3.4739,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":{"value":0.95163345,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"21","issue":"1","first_page":"138","last_page":"138"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ceritinib","display_name":"ceritinib","score":0.9430000185966492},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/androgen-receptor","display_name":"androgen receptor","score":0.9940000176429749},{"id":"https://openalex.org/keywords/enzalutamide","display_name":"enzalutamide","score":0.9539999961853027},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9789999723434448},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8140000104904175},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.7649999856948853},{"id":"https://openalex.org/keywords/paclitaxel-resistance","display_name":"paclitaxel resistance","score":0.9700000286102295},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.6980000138282776},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.7070000171661377},{"id":"https://openalex.org/keywords/mouse-xenograft-model","display_name":"xenograft mouse model","score":0.8050000071525574}],"concepts":[{"id":"https://openalex.org/C2779750558","wikidata":"https://www.wikidata.org/wiki/Q21011233","display_name":"Ceritinib","level":5,"score":0.9880465269088745},{"id":"https://openalex.org/C2779422266","wikidata":"https://www.wikidata.org/wiki/Q5186964","display_name":"Crizotinib","level":4,"score":0.8427201509475708},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.7724652886390686},{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.7487708330154419},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7262955904006958},{"id":"https://openalex.org/C117643217","wikidata":"https://www.wikidata.org/wiki/Q17824987","display_name":"Anaplastic lymphoma kinase","level":4,"score":0.584716796875},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.5670363306999207},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.4973759949207306},{"id":"https://openalex.org/C2778347629","wikidata":"https://www.wikidata.org/wiki/Q4652380","display_name":"ALK inhibitor","level":5,"score":0.4785783290863037},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.47404953837394714},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4608911871910095},{"id":"https://openalex.org/C2779220645","wikidata":"https://www.wikidata.org/wiki/Q21099132","display_name":"Alectinib","level":5,"score":0.4557095170021057},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4186607003211975},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.39974871277809143},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37344372272491455},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.33461621403694153},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29630595445632935},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.29268985986709595},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000728","descriptor_name":"Androgens","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011944","descriptor_name":"Receptors, Androgen","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011944","descriptor_name":"Receptors, Androgen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013450","descriptor_name":"Sulfones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D064726","descriptor_name":"Triple Negative Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1186/s12943-022-01601-0","doi":"https://doi.org/10.1186/s12943-022-01601-0","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12943-022-01601-0","pdf_url":null,"source":{"id":"https://openalex.org/S132829192","display_name":"Molecular Cancer","issn_l":"1476-4598","issn":["1476-4598"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9241294","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9241294","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Cancer","raw_type":"Text"},{"id":"pmid:35768871","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35768871","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:c21df2546bf34c64b07e78a26f6cb56b","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/c21df2546bf34c64b07e78a26f6cb56b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Molecular Cancer, Vol 21, Iss 1, Pp 1-16 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s12943-022-01601-0","doi":"https://doi.org/10.1186/s12943-022-01601-0","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s12943-022-01601-0","pdf_url":null,"source":{"id":"https://openalex.org/S132829192","display_name":"Molecular Cancer","issn_l":"1476-4598","issn":["1476-4598"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":53,"referenced_works":["https://openalex.org/W211315521","https://openalex.org/W1864088128","https://openalex.org/W1968786809","https://openalex.org/W1974903221","https://openalex.org/W1981218708","https://openalex.org/W1987117672","https://openalex.org/W2035894835","https://openalex.org/W2043152591","https://openalex.org/W2055013229","https://openalex.org/W2073908787","https://openalex.org/W2088190208","https://openalex.org/W2098804778","https://openalex.org/W2107617686","https://openalex.org/W2111393163","https://openalex.org/W2115727543","https://openalex.org/W2123394258","https://openalex.org/W2129420347","https://openalex.org/W2138213364","https://openalex.org/W2139517025","https://openalex.org/W2141630969","https://openalex.org/W2145702083","https://openalex.org/W2145801998","https://openalex.org/W2147343434","https://openalex.org/W2157586615","https://openalex.org/W2162765338","https://openalex.org/W2164953703","https://openalex.org/W2211064704","https://openalex.org/W2340829607","https://openalex.org/W2430731787","https://openalex.org/W2551769070","https://openalex.org/W2607666115","https://openalex.org/W2616832580","https://openalex.org/W2626401975","https://openalex.org/W2747219892","https://openalex.org/W2760328201","https://openalex.org/W2764184942","https://openalex.org/W2769267582","https://openalex.org/W2784775153","https://openalex.org/W2795063553","https://openalex.org/W2807966236","https://openalex.org/W2907673368","https://openalex.org/W2964973927","https://openalex.org/W3003627105","https://openalex.org/W3040585876","https://openalex.org/W3093085805","https://openalex.org/W3093154039","https://openalex.org/W3113189792","https://openalex.org/W3113812720","https://openalex.org/W3125030632","https://openalex.org/W3136341704","https://openalex.org/W3160798986","https://openalex.org/W3163351132","https://openalex.org/W3163365295"],"related_works":["https://openalex.org/W6958083117","https://openalex.org/W4312097907","https://openalex.org/W6939540692","https://openalex.org/W3136625942","https://openalex.org/W6958321396","https://openalex.org/W1175072732","https://openalex.org/W2279208322","https://openalex.org/W2517022125","https://openalex.org/W2292180879","https://openalex.org/W2221943220"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Triple-negative":[2],"breast":[3,11,44,115],"cancers":[4],"(TNBCs)":[5],"are":[6,329],"clinically":[7],"aggressive":[8],"subtypes":[9],"of":[10,25,40,50,72,82,107,123,152,184,201,213,236,241,248,262,276,289,303],"cancer.":[12,104],"TNBC":[13,63,154,197,215,237,283],"is":[14,67,77,88,99],"difficult":[15],"to":[16,22,101,230,252,280,319],"treat":[17,102,281],"with":[18],"targeted":[19,27],"agents":[20,324],"due":[21],"the":[23,48,80,94,157,182,260,286,333,342],"lack":[24],"commonly":[26],"therapies":[28],"within":[29],"this":[30,314],"subtype.":[31],"Androgen":[32],"receptor":[33,52,96],"(AR)":[34],"has":[35,56,168],"been":[36],"detected":[37],"in":[38,47,62,79,173,195,217,220,233,265,326,341],"12\u201355%":[39],"TNBCs.":[41],"AR":[42,113,131,176,263,266,293,308],"stimulates":[43],"tumor":[45,249,317],"growth":[46,212,250,318],"absence":[49],"estrogen":[51],"(ER),":[53],"and":[54,75,97,125,130,135,164,191,203,219,243,278,291,305,313,331],"it":[55,76,98],"become":[57],"an":[58],"emerging":[59],"molecular":[60],"target":[61],"treatment.":[64],"Methods":[65],"Ceritinib":[66,186,223],"a":[68,89,149,169,206,253,271,299,320],"small":[69,90],"molecule":[70,91],"inhibitor":[71],"tyrosine":[73],"kinase":[74],"used":[78,100,325],"therapy":[81,106,336],"non-small":[83],"lung":[84],"cancer":[85,116],"patients.":[86],"Enzalutamide":[87],"compound":[92],"targeting":[93],"androgen":[95,174],"prostate":[103],"Combination":[105],"these":[108],"drugs":[109,146],"were":[110],"investigated":[111,127,181],"using":[112,128],"positive":[114,267],"mouse":[117,133],"xenograft":[118,134,138],"models.":[119,139],"Also,":[120],"combination":[121,200,240,302,315,335],"treatment":[122,187],"ceritinib":[124,163,167,202,244,279,304],"paclitaxel":[126,231,242,306],"AR\u2212":[129],"low":[132],"patient":[136],"derived":[137],"Results":[140],"We":[141],"screened":[142],"133":[143],"FDA":[144],"approved":[145],"that":[147,228],"have":[148],"therapeutic":[150,301],"effect":[151,183,209],"AR+":[153,196,214,282],"cells.":[155,198,238],"From":[156],"screen,":[158],"we":[159,179,269,297],"identified":[160],"two":[161],"drugs,":[162],"crizotinib.":[165],"Since":[166],"well-":[170],"defined":[171],"role":[172],"independent":[175],"signaling":[177,226,294],"pathways,":[178],"further":[180],"ceritinib.":[185],"inhibited":[188,316],"RTK/ACK/AR":[189],"pathway":[190,227],"other":[192],"downstream":[193],"pathways":[194],"The":[199,239],"enzalutamide":[204,277],"showed":[205,245],"robust":[207],"inhibitory":[208],"on":[210],"cell":[211],"cells":[216],"vitro":[218],"vivo.":[221],"Interestingly":[222],"inhibits":[224],"FAK-YB-1":[225],"leads":[229],"resistance":[232],"all":[234],"types":[235],"drastic":[246],"inhibition":[247],"compared":[251],"single":[254],"drug":[255],"alone.":[256],"Conclusions":[257],"To":[258],"improve":[259],"response":[261],"antagonist":[264],"TNBC,":[268],"designed":[270],"novel":[272,300],"combinational":[273],"strategy":[274],"comprised":[275],"tumors":[284],"through":[285],"dual":[287],"blockade":[288],"androgen-dependent":[290],"androgen-independent":[292],"pathways.":[295],"Furthermore,":[296],"introduced":[298],"for":[307],"negative":[309],"or":[310],"AR-low":[311],"TNBCs":[312],"great":[321],"extent.":[322],"All":[323],"our":[327],"study":[328],"FDA-approved,":[330],"thus":[332],"proposed":[334],"will":[337],"likely":[338],"be":[339],"useful":[340],"clinic.":[343]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-06-30T00:00:00"}